Coherus Oncology, Inc 10-Q for FY2021 Q1
Coherus Oncology, Inc. (CHRS)
10-Q
2021-05-06
For: 2021-03-31
View Original
Added on
April 09, 2026
About this 10-Q
Coherus Oncology, Inc filed this 10-Q on May 6, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $83.03M
- down 28.5% from $116.18M a year earlier
- Net loss
- $172.95M
- compared with net income of $35.57M a year earlier
- Diluted EPS
- -$2.37
- compared with $0.48 a year earlier